Thermo Fisher Scientific Inc. (TMO) Stake Maintained by Supplemental Annuity Collective Trust of NJ

Thermo Fisher Scientific Inc. (TMO) Stake Maintained by Supplemental Annuity Collective Trust of NJ

Supplemental Annuity Collective Trust of NJ held its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,813 shares of the company’s stock at the end of the second quarter. Supplemental Annuity Collective Trust of NJ’s holdings in Thermo Fisher Scientific were worth $1,302,000 as of its most recent filing with the SEC.

A number of other large investors have also bought and sold shares of the company. Wellington Management Group LLP boosted its stake in Thermo Fisher Scientific by 26.0% in the first quarter. Wellington Management Group LLP now owns 6,135,669 shares of the company’s stock valued at $868,749,000 after buying an additional 1,267,967 shares during the last quarter. Carmignac Gestion boosted its stake in Thermo Fisher Scientific by 23.3% in the second quarter. Carmignac Gestion now owns 4,046,550 shares of the company’s stock valued at $597,918,000 after buying an additional 763,421 shares during the last quarter. Columbus Circle Investors boosted its stake in Thermo Fisher Scientific by 363.2% in the second quarter. Columbus Circle Investors now owns 668,109 shares of the company’s stock valued at $98,720,000 after buying an additional 523,867 shares during the last quarter. Bank of Montreal Can acquired a new stake in Thermo Fisher Scientific during the second quarter valued at $32,053,000. Finally, Samlyn Capital LLC acquired a new stake in Thermo Fisher Scientific during the first quarter valued at $22,229,000. Hedge funds and other institutional investors own 87.38% of the company’s stock.

Thermo Fisher Scientific Inc. (NYSE:TMO) traded down 1.35% during mid-day trading on Friday, reaching $147.21. The company’s stock had a trading volume of 1,805,911 shares. Thermo Fisher Scientific Inc. has a 1-year low of $119.75 and a 1-year high of $160.68. The firm has a 50 day moving average price of $153.04 and a 200-day moving average price of $151.59. The company has a market capitalization of $58.04 billion, a PE ratio of 29.45 and a beta of 0.97.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Thursday, October 27th. The company reported $2.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.97 by $0.06. The business had revenue of $4.49 billion for the quarter, compared to the consensus estimate of $4.39 billion. Thermo Fisher Scientific had a return on equity of 14.95% and a net margin of 11.10%. The business’s revenue was up 8.9% on a year-over-year basis. During the same quarter last year, the business posted $1.80 EPS. On average, equities analysts predict that Thermo Fisher Scientific Inc. will post $8.22 EPS for the current fiscal year.

A number of brokerages have weighed in on TMO. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $175.00 price objective for the company in a research note on Wednesday, July 20th. BTIG Research upgraded Thermo Fisher Scientific from a “neutral” rating to a “buy” rating and set a $180.00 price objective for the company in a research note on Friday, July 22nd. Bank of America Corp. set a $180.00 price objective on Thermo Fisher Scientific and gave the company a “buy” rating in a research note on Friday, October 7th. Cleveland Research cut Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a research note on Friday, September 9th. Finally, Mizuho set a $175.00 price objective on Thermo Fisher Scientific and gave the company a “buy” rating in a research note on Thursday, July 28th. Two research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. Thermo Fisher Scientific has an average rating of “Buy” and a consensus target price of $162.37.

In other Thermo Fisher Scientific news, SVP Daniel P. Shine sold 1,699 shares of Thermo Fisher Scientific stock in a transaction on Monday, August 29th. The stock was sold at an average price of $152.28, for a total transaction of $258,723.72. Following the sale, the senior vice president now owns 17,437 shares of the company’s stock, valued at approximately $2,655,306.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director C Martin Harris sold 390 shares of Thermo Fisher Scientific stock in a transaction on Friday, August 5th. The shares were sold at an average price of $157.33, for a total value of $61,358.70. Following the sale, the director now directly owns 4,648 shares in the company, valued at approximately $731,269.84. The disclosure for this sale can be found here. 0.52% of the stock is owned by corporate insiders.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Related posts

Leave a Comment